- Treats 20+ neuromuscular (NM) conditions (stroke, cerebral palsy, chronic pain, incontinence)
- Total market spend of $550B worldwide for NM conditions. Addressable market of $55B for JOGO
- FDA cleared, patent with 18 claims. Medicare and insurance approved.
- Co-Founder’s previous AI venture was acquired by IQVIA, world’s largest clinical research company
JOGO treats stroke, chronic pain and urinary incontinence using wearable sensors, AI and Virtual Reality through Telemedicine
JOGO wants to be the leader in tele rehabilitation to help patients with neuro-muscular conditions, chronic pain and incontinence receive world class rehab at home without travelling to expensive rehabilitation hospitals.